company background image
600165 logo

Ningxia Zhongke Biotechnology SHSE:600165 Stock Report

Last Price

CN¥1.63

Market Cap

CN¥1.1b

7D

-15.1%

1Y

-62.6%

Updated

26 Apr, 2024

Data

Company Financials

Ningxia Zhongke Biotechnology Co., Ltd

SHSE:600165 Stock Report

Market Cap: CN¥1.1b

600165 Stock Overview

Ningxia Zhongke Biotechnology Co., Ltd. produces and sells coal-based activated carbon and lauric acid products.

600165 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Ningxia Zhongke Biotechnology Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ningxia Zhongke Biotechnology
Historical stock prices
Current Share PriceCN¥1.63
52 Week HighCN¥4.99
52 Week LowCN¥1.42
Beta0.92
1 Month Change-59.25%
3 Month Change-45.85%
1 Year Change-62.61%
3 Year Change-70.74%
5 Year Change-67.85%
Change since IPO-41.63%

Recent News & Updates

Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Apr 21
Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

Feb 27
Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

Recent updates

Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Apr 21
Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

Feb 27
Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

Shareholder Returns

600165CN ChemicalsCN Market
7D-15.1%-0.7%-0.3%
1Y-62.6%-20.7%-14.6%

Return vs Industry: 600165 underperformed the CN Chemicals industry which returned -20.7% over the past year.

Return vs Market: 600165 underperformed the CN Market which returned -14.6% over the past year.

Price Volatility

Is 600165's price volatile compared to industry and market?
600165 volatility
600165 Average Weekly Movement14.6%
Chemicals Industry Average Movement8.6%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 600165's share price has been volatile over the past 3 months.

Volatility Over Time: 600165's weekly volatility has increased from 8% to 15% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1958908Rui Chenwww.xinrihengli.com

Ningxia Zhongke Biotechnology Co., Ltd. produces and sells coal-based activated carbon and lauric acid products. The company was founded in 1998 and is based in Yinchuan, China.

Ningxia Zhongke Biotechnology Co., Ltd Fundamentals Summary

How do Ningxia Zhongke Biotechnology's earnings and revenue compare to its market cap?
600165 fundamental statistics
Market capCN¥1.12b
Earnings (TTM)-CN¥340.29m
Revenue (TTM)CN¥243.62m

4.6x

P/S Ratio

-3.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600165 income statement (TTM)
RevenueCN¥243.62m
Cost of RevenueCN¥335.52m
Gross Profit-CN¥91.90m
Other ExpensesCN¥248.39m
Earnings-CN¥340.29m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)-0.50
Gross Margin-37.72%
Net Profit Margin-139.68%
Debt/Equity Ratio268.9%

How did 600165 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.